PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för satavaptan. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

5 hits

Bibliografisk träff 2022-08-16

Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality.

Gantzel RH, Aagaard NK, Vilstrup H, Watson H, Grønbæk H, Jepsen P.

Hepatol Commun · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1002/hep4.2065

Bibliografisk träff 2013-11-20

Global analysis of the effects of the V2 receptor antagonist satavaptan on protein phosphorylation in collecting duct.

Hoffert JD, Pisitkun T, Saeed F, Wilson JL, Knepper MA.

Am J Physiol Renal Physiol · research support, n.i.h., intramural; research-article; journal article · DOI 10.1152/ajprenal.00497.2013

Bibliografisk träff 2001-10-01

SR-121463. Sanofi-Synthélabo.

Martinez-Castelao A.

Curr Opin Investig Drugs · review; journal article

Bibliografisk träff 2000-10-01

Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats.

Jiménez W, Gal CS, Ros J, Cano C, Cejudo P, Morales-Ruiz M, Arroyo V, Pascal M, Rivera F, Maffrand JP, Rodés J.

J Pharmacol Exp Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(24)38872-x

Bibliografisk träff 1996-12-01

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

Serradeil-Le Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Brossard G, Nisato D, Maffrand JP, Le Fur G.

J Clin Invest · research-article; journal article · DOI 10.1172/jci119098